Clinical trial

Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

NCT00031889

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-08-01

PhasePHASE2

Study timeline

Study start (unknown)2001-08-01Date precision: month

Registry last updated2012-05-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

ExemestaneDRUG · verified · RxNorm: exemestane

Exemestane+bicalutamideDRUG

Sponsors & collaborators

Swiss Cancer Institutelead sponsor

Mapped research locations

ZurichSwitzerland1 BaselSwitzerland1 BernSwitzerland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00031889 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.